This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
ORIGINAL RESEARCH PAPER
Bernardo, B. C. et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl Acad. Sci. USA 109, 17615–17620 (2012)
Rights and permissions
About this article
Cite this article
Harrison, C. Inhibiting microRNA-34 benefits heart disease. Nat Rev Drug Discov 11, 908 (2012). https://doi.org/10.1038/nrd3903
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd3903